Inquiry Basket
Catalog | Product Name | CAS Number |
---|---|---|
BADC-01571 | Fmoc-Dap-OH | 863971-41-9 |
Fmoc-Dap-OH is an important compound in the field of biomedicine and plays an indispensable role in the complex process of synthesizing various drugs and peptides. This compound is particularly prized for its unique efficacy against infectious diseases and cancer,and has become the cornerstone of the invention of cutting-edge therapies aimed at fighting drug-resistant pathogens or preventing the proliferation of malignant tumors. | Inquiry | |
BADC-01572 | N-Boc-Dap-Phe-OH | |
Boc-Dap-OH.DCHA is a biomedical chemical product with a variety of potential applications. As a promising small molecule reagent, it is widely used in the field of bioconjugation, especially antibody-drug conjugation. | Inquiry | |
BADC-01573 | N-Boc-Dap-Phe-OMe | 161485-82-1 |
N-Boc-Dap-Phe-OMe is a biomedical chemical product with a variety of potential applications. As a targeted drug delivery system, it plays an effective role in the comprehensive treatment of various diseases. | Inquiry | |
BADC-01574 | Dov-Val-Dil-OtBu | 120205-53-0 |
Dov-Val-Dil-OtBu is a remarkable biomedicine chemical in the arena of cardiovascular therapeutic interventions. Positioned as an indispensable inhibitor targeting the exquisitely intricate enzyme network, it propels precision in blood pressure modulation and orchestrates the harmonious functioning of the heart. | Inquiry | |
BADC-01575 | Dov-Val-Dil-OH | 133120-89-5 |
Dov-Val-Dil-OH is an intermediate of dolastoxin, a cytotoxic liner peptide produced by Dolabbella auriclaria which exhibits potent antitumor activity. | Inquiry | |
BADC-01576 | Dov-Val-Dil-OH TFA | 133120-90-8 |
Dov-Val-Dil-OH TFA is a pharmaceutical compound whose full name is N-(2,2-dimethyl-1,3-dioxolane-4-yl)valine trifluoroacetate. It is a peptide derivative used in pharmaceutical research and development. | Inquiry | |
BADC-01577 | N-Boc-amino-PEG3-acid | 1365655-91-9 |
N-Boc-amino-PEG3-acid is a PEG derivative containing a terminal carboxylic acid and Boc-protected amino group. | Inquiry | |
BADC-01578 | Mal-amido-PEG2-acid | 756525-98-1 |
Mal-amido-PEG2-acid is a PEG linker containing a maleimide group and a terminal carboxylic acid. | Inquiry | |
BADC-01579 | N-Boc-9-azabicyclo[3.3.1]nonan-3-one | 512822-27-4 |
N-Boc-9-azabicyclo[3.3.1]nonan-3-one (CAS# 512822-27-4) is a useful research chemical. | Inquiry | |
BADC-01580 | Tert-butyl 9-oxo-3-azabicyclo[3.3.1]nonane-3-carboxylate | 512822-34-3 |
Tert-butyl 9-oxo-3-azabicyclo[3.3.1]nonane-3-carboxylate is an extremely complex compound with a wide range of uses in the biomedical field. Tailored to target insidious bacterial invasions, cancerous dangers, or troublesome neurological dysfunction, this compound is incredibly versatile. | Inquiry | |
BADC-01581 | 9-Boc-7-oxa-9-azabicyclo[3.3.1]nonan-3-one | 280761-97-9 |
9-Boc-7-oxa-9-azabicyclo[3.3.1]nonan-3-one (CAS# 280761-97-9) is a useful research chemical. | Inquiry | |
BADC-01582 | KetoABNO | 7123-92-4 |
KetoABNO is a well-known antibody drug that strategically targets multiple cancer types prevalent in the biomedical field, such as breast, lung and colon cancer. This special compound can effectively avoid cancer-causing signaling pathways and perfectly prevent tumor expansion. | Inquiry | |
BADC-01583 | 9-Azabicyclo[3.3.1]nonane n-oxyl | 31785-68-9 |
9-Azabicyclo[3.3.1]nonane n-oxyl is a remarkable multifaceted compound. This compound is known for its excellent antioxidant properties and is widely used in the field of drug innovation. Notably, its therapeutic capabilities span a range of diseases, including neurodegenerative and cardiovascular diseases. Interestingly, the unique molecular structure of this compound plays a key role in its efficacy as a drug against oxidative stress and related pathophysiological disruptions. | Inquiry | |
BADC-01584 | Tert-butyl 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-oxa-9-azabicyclo[3.3.1]non-6-ene-9-carboxylate | 1313034-29-5 |
Tert-butyl 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-oxa-9-azabicyclo[3.3.1]non-6-ene-9-carboxylate is a biomedical product used for the drug development of certain diseases. It exhibits potential in targeting specific protein receptors implicated in various drug-resistant cancers, making it a promising candidate for anticancer therapies. | Inquiry | |
BADC-01585 | 9-Azabicyclo[3.3.1]nonan-3-one Hydrochloride | 72761-60-5 |
9-Azabicyclo[3.3.1]nonan-3-one Hydrochloride (CAS# 72761-60-5) is a useful research chemical. | Inquiry | |
BADC-01587 | Gly-Gly-Gly-Gly-OH | 637-84-3 |
Gly-Gly-Gly-Gly-OH is a very versatile peptide mimetic compound. This cleavable linker stands out through its careful design in complex drug delivery systems, promising profound implications in the fight against a variety of diseases including cancer, neurodegenerative diseases, and cardiovascular diseases. | Inquiry | |
BADC-01588 | Gly-Gly-Phe-OH | 6234-26-0 |
Gly-Gly-Phe-OH is a cleavable peptide linker that is widely used in the development of antibody-drug conjugates. Furthermore, Gly-Gly-Phe-OH brings hope to the field of oncology research, having demonstrated its ability as a targeted therapeutic moiety to selectively target tumor cells with high precision. | Inquiry | |
BADC-01589 | Fmoc-Lys(IvDde)-OH | 204777-78-6 |
The ivDde protective group possesses higher orthogonality regarding Boc and Fmoc in comparison to Dde. | Inquiry | |
BADC-01590 | exo-3-Amino-9-Boc-9-azabicyclo[3.3.1]nonane | 1363380-67-9 |
exo-3-Amino-9-Boc-9-azabicyclo[3.3.1]nonane is a precursor in drug synthesis. This compound serves as a key intermediate in the development of a variety of drugs for central nervous system diseases, including but not limited to Alzheimer's disease and Parkinson's disease. | Inquiry | |
BADC-01591 | Boc-Dap-OH | 120205-50-7 |
Boc-Dap-OH is a pivotal compound extensively utilized in the biomedical sector. It assumes a fundamental function in the amalgamation of diverse pharmaceutical remedies and peptides. This indispensable product profoundly contributes to the progression of therapeutics targeting ailments like cancer and viral infections. | Inquiry |